Authors: Alvarez, D.; Wiley, R.E.; Jordana, M.

Source: Current Drug Metabolism, Volume 7, Number 11, 1 July 2001 , pp. 1059-1081(23)

Publisher: Bentham Science Publishers

Abstract:

Although current pharmacopoeia is effective in alleviating asthma symptomatology, it is equally unable to modify the fundamental immunological basis of the allergic diathesis. The explosion in knowledge of the immunobiology of cytokines that has occurred in the last decade has remarkably clarified our understanding of the pathogenesis of allergic asthma, and has unleashed a plethora of compelling opportunities. In the first part of this review, we will summarize current knowledge on the pathogenesis of allergic asthma, with particular emphasis on relevant cytokine networks. This will position us to appraise critically initiatives in the search to modulate cytokine targets that are key to the expression of the allergic asthma phenotype. We will review the use of recombinant cytokines, soluble cytokine receptors, cytokine receptor antagonists and cytokine inhibitors, in pre-clinical and clinical development. Finally, we will assess the applicability of transgene-based modalities, including anti-sense oligonucleotide technology and gene therapy, as novel therapeutic strategies in the treatment of allergic Asthma.

Keywords: Cytokine Therapeutics; Asthma; Recombinant cytokines; Cytokine receptors; VCAM-1; Pro-Inflammatory Cytokines; Th2-Associated Cytokines; Anti-Inflammatory Cytokines; Interferon; TRANSGENE-BASED MODALITIES

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612013397582

Publication date: 2001-07-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Alvarez, D. ;  Wiley, R.E. ;  Jordana, M.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers